This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...

By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...

Oil and pharmaceutical companies bore the brunt of heavy selling as the FTSE 100 index and other European bourses fell ...

Britain will invest up to $767 million into a new health data research service to help boost scientific studies and cut the ...

Ohio and Indiana are suing the makers of a popular heartburn medication, saying the drug company concealed cancer risks and ...

A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...

Pfizer denied the allegations and argued GSK's patents were invalid. It convinced a London court to invalidate related UK patents owned by GSK in a separate case last year. GSK has also sued ...

Pfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing ...